Skip to main content

Sage Therapeutics, Inc.

SAGEDelisted Jul 31, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001597553

Sage Therapeutics, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Jul 31, 2025; 192 institutions reported holding it in 13F filings for Q2 2025, worth $445.6M in total; no superinvestor held it.

13F holders, Q4 2021

Institutional positions in Sage Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
217
−7 vs. Q3 2021
Shares held
50.2M
+1.33M (+2.7%) vs. Q3 2021
Total value
$2.14B
−$30.0M (−1.4%) vs. Q3 2021
New holders
27
78 more added
Sold out
34
74 more reduced

3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SAGE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 217 institutions
Q1 2021: 263 institutionsQ2 2021: 257 institutionsQ3 2021: 227 institutionsQ4 2021: 217 institutionsQ1 2022: 212 institutionsQ2 2022: 211 institutionsQ3 2022: 201 institutionsQ4 2022: 207 institutionsQ1 2023: 214 institutionsQ2 2023: 225 institutionsQ3 2023: 195 institutionsQ4 2023: 202 institutionsQ1 2024: 206 institutionsQ2 2024: 196 institutionsQ3 2024: 177 institutionsQ4 2024: 177 institutionsQ1 2025: 198 institutionsQ2 2025: 192 institutionsQ3 2025: 5 institutionsQ4 2025: 2 institutionsQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ4 2021: $2.14B
Q1 2021: $3.97BQ2 2021: $2.88BQ3 2021: $2.17BQ4 2021: $2.14BQ1 2022: $1.65BQ2 2022: $1.65BQ3 2022: $2.02BQ4 2022: $1.97BQ1 2023: $2.22BQ2 2023: $2.54BQ3 2023: $1.21BQ4 2023: $1.22BQ1 2024: $1.10BQ2 2024: $581.3MQ3 2024: $373.7MQ4 2024: $278.2MQ1 2025: $411.4MQ2 2025: $445.6MQ3 2025: $494.0KQ4 2025: $460.0KQ1 2026: $9Q2 2026: $9
Institutions holding SAGE and their total value by quarter
QuarterHoldersValue
Q2 20261$9
Q1 20261$9
Q4 20252$460.0K
Q3 20255$494.0K
Q2 2025192$445.6M
Q1 2025198$411.4M
Q4 2024177$278.2M
Q3 2024177$373.7M
Q2 2024196$581.3M
Q1 2024206$1.10B
Q4 2023202$1.22B
Q3 2023195$1.21B
Q2 2023225$2.54B
Q1 2023214$2.22B
Q4 2022207$1.97B
Q3 2022201$2.02B
Q2 2022211$1.65B
Q1 2022212$1.65B
Q4 2021217$2.14B
Q3 2021227$2.17B
Q2 2021257$2.88B
Q1 2021263$3.97B

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Sage Therapeutics, Inc.; share changes are against Q3 2021.

Institutions holding SAGE in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Palo Alto Investors LP781,730$33.3M2.13%+163,800+26.5%Added
First Trust Advisors LP811,434$34.5M0.03%+222,395+37.8%Added
Geode Capital Management, LLC908,229$38.6M0.00%+33,424+3.8%Added
EcoR1 Capital, LLC940,636$40.0M1.28%+940,636New
Janus Henderson Group PLC974,982$41.5M0.02%−76,011−7.2%Reduced
D. E. Shaw & Co., Inc.994,269$42.3M0.05%−262,022−20.9%Reduced
Artal Group S.A.1,000,000$42.5M1.25%00.0%Unchanged
Boxer Capital, LLC1,094,000$46.5M1.85%00.0%Unchanged
Citadel Advisors LLC1,097,845$46.7M0.05%+427,855+63.9%Added
Price T Rowe Associates Inc1,416,522$60.3M0.01%+9,633+0.7%Added
JPMorgan Chase & Co1,561,622$66.4M0.01%+397,001+34.1%Added
State Street Corp2,168,530$92.2M0.00%+192,578+9.7%Added
BlackRock Inc.2,779,437$118.2M0.00%−95,118−3.3%Reduced
Bellevue Group AG3,228,004$137.3M1.42%+19,000+0.6%Added
Vanguard Group Inc4,578,241$194.8M0.00%−253,028−5.2%Reduced
FMR LLC5,490,574$233.6M0.02%−146,510−2.6%Reduced
Wellington Management Group LLP7,126,411$303.2M0.05%+356,478+5.3%Added
Great Point Partners LLC0$00.00%−269,010−100.0%Sold out
Asymmetry Capital Management, L.P.0$00.00%−229,117−100.0%Sold out
Candriam Luxembourg S.C.A.0$00.00%−185,058−100.0%Sold out
Assetmark, Inc0$00.00%−81,946−100.0%Sold out
Allianz Asset Management GmbH0$00.00%−75,768−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−52,134−100.0%Sold out
Natixis0$00.00%−34,900−100.0%Sold out
Woodline Partners LP0$00.00%−34,813−100.0%Sold out
Assenagon Asset Management S.A.0$00.00%−32,017−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−28,697−100.0%Sold out
Lazard Asset Management LLC0$00.00%−27,292−100.0%Sold out
Polianta Ltd0$00.00%−25,400−100.0%Sold out
Seven Eight Capital, LP0$00.00%−20,397−100.0%Sold out
Skandinaviska Enskilda Banken AB (publ)0$00.00%−12,608−100.0%Sold out
Duality Advisers, LP0$00.00%−10,641−100.0%Sold out
Meeder Asset Management Inc0$00.00%−7,995−100.0%Sold out
Weiss Multi-Strategy Advisers LLC0$00.00%−6,602−100.0%Sold out
Fox Run Management, L.L.C.0$00.00%−6,597−100.0%Sold out
Pinebridge Investments, L.P.0$00.00%−6,427−100.0%Sold out
XTX Topco Ltd0$00.00%−5,991−100.0%Sold out
Employees Retirement System of Texas0$00.00%−5,508−100.0%Sold out
Fairfield, Bush & Co.0$00.00%−5,000−100.0%Sold out
Capula Management Ltd0$00.00%−5,014−100.0%Sold out
Man Group plc0$00.00%−4,603−100.0%Sold out
Penserra Capital Management LLC0$00.00%−1,345−100.0%Sold out
Van Eck Associates Corp0$00.00%−1,203−100.0%Sold out
AdvisorNet Financial, Inc0$00.00%−310−100.0%Sold out
Loomis Sayles & Co L P0$00.00%−166−100.0%Sold out
Creative Financial Designs Inc0$00.00%−124−100.0%Sold out
Evolution Wealth Advisors, LLC0$00.00%−60−100.0%Sold out
BerganKDV Wealth Management, LLC0$00.00%−41−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−55−100.0%Sold out
Walled Lake Planning & Wealth Management, LLC0$00.00%−44−100.0%Sold out
Meridian Wealth Partners, LLC0$00.00%−5−100.0%Sold out
Marshall Wace North America L.P.––––Not filed
Berman Capital Advisors, LLC––––Not filed
Sonora Investment Management, LLC––––Not filed